ERIS

Eris Lifesciences Limited

Pharmaceuticals

Share price

₹1,185

Market cap

₹16,477 Cr

1Y return

▼ 26%

A pharmaceutical manufacturer and marketer, ERIS Lifesciences produces branded and generic drugs across multiple therapeutic areas including cardiovascular, gastroenterology, and anti-infective segments. The company operates manufacturing facilities and distributes medications through established distribution networks to serve both domestic and international markets. It focuses on developing and delivering cost-effective pharmaceutical formulations for diverse patient populations.

Investors holding Eris Lifesciences Limited

HSBC Mutual Fund

Mutual Fund

1.03%

Recent moves 4

HSBC Mutual FundNew position

HSBC Mutual Fund entered Eris Lifesciences Limited with 14,25,613 shares, a 1.03% stake worth ₹207.57 crore at ₹1455.40 apiece.

UTI Mutual FundDecreased

UTI Mutual Fund decreased its stake in Eris Lifesciences from 1.92% to 1.58% by selling 4,67,922 shares. The value of shares sold is ₹68.09 Cr at ₹1455.40 apiece.

Franklin Templeton Mutual FundIncreased

Franklin Templeton Mutual Fund increased its stake in Eris Lifesciences from 4.06% to 4.29%, buying 329,077 shares. In July, Franklin Templeton Mutual Fund had bought 10.94 lakh shares of Eris Lifesciences for ₹109.42 crore at ₹1,000.04 apiece.

HDFC Mutual FundDecreased

HDFC Mutual Fund decreased its stake in Eris Lifesciences from 8.46% to 8.33% by selling 1,81,030 shares.

Track the whales in Eris Lifesciences Limited

Get alerted the moment a top investor buys or sells.